Radiation and Tissue Expander; What Should I Know?
The indications for radiation therapy after mastectomy may include larger tumor size, nodal metastasis, or involved or close surgical margins. In some scenarios, the need for radiation is known prior to the mastectomy, and in other cases, it’s not determined until after the mastectomy, when the final pathologic stage is determined.
Occasionally, a tissue expander, which is a temporary implant, may be used as a placeholder at the time of the mastectomy to allow for further cancer treatment, i.e. chemotherapy and/or radiation therapy. The tissue expander helps preserve more skin on the chest wall and creates a temporary breast mound during cancer treatments so that you feel and look normal in clothing.
After all the treatments are concluded, the tissue expander is then exchanged for either an implant or tissue-based reconstruction. Patients who elect to have a permanent implant placed are at higher risks for both short-term and long-term complications. Short term complications include infection and extrusion of the implant while long term risks include an accelerated progression to capsular contracture. Tissue-based reconstruction offers a safer alternative for patients requiring radiation therapy after a mastectomy as the overall complications do not differ from non-radiated patients.
The decision to use a tissue expander is unique to each patient as it is influenced by the overall cancer treatment plan. Please contact us at Breast Reconstruction Associates so we can work with you, your breast surgeon, and your radiation oncologist to determine the best reconstruction strategy.
FAQs
A tissue expander is a temporary implant placed at the time of mastectomy to preserve chest wall skin and create a temporary breast mound, allowing patients to look and feel normal in clothing while undergoing cancer treatments like chemotherapy or radiation.
Radiation may be recommended for patients with larger tumor sizes, lymph node metastasis, or surgical margins that are involved or close to cancerous tissue.
Not always. In some cases, the need for radiation is known before mastectomy, but in others, it’s determined only after surgery once the final pathologic stage is assessed.
Once all cancer treatments are finished, the tissue expander is exchanged for either a permanent implant or tissue-based reconstruction, depending on what’s best for the patient.
? Patients choosing a permanent implant face higher short-term risks like infection and implant extrusion, as well as long-term risks such as accelerated capsular contracture.
Yes. Tissue-based reconstruction is generally considered safer for patients who have undergone radiation, as overall complication rates are comparable to those of non-radiated patients.
The decision is highly individualized, based on the overall cancer treatment plan, and involves collaboration between the patient, breast surgeon, and radiation oncologist to determine the most appropriate reconstruction strategy.